EpiCept Announces Pricing of Public Offering

Posted on: Wednesday, 16 July 2008, 00:00 CDT Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) announced today the pricing of a public offering of 2 million shares of its common stock at $.25 per share and five-year warrants to purchase up to 2 million shares of common stock at an exercise price of $.39 per share. EpiCept will receive approximately $0.5 million in net proceeds from the offering. Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (Nasdaq: RODM) acted as the exclusive placement agent for the offering. EpiCept intends to use the net proceeds it receives to meet working capital needs and general corporate purposes. The proposed public offering is being made pursuant to an effective registration statement, and may be made only by means of a prospectus and... [read full story]